MDWD · MediWound Ltd. · Insider Trading

$13.77 -0.03 (-0.22%) At close · Sep 30

Russell 2000 member Rebalance outlook locked

Market Cap

$178.68M

12.91M

Volume · Sep 30 83.89K Avg daily vol (3M) 85.58K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-1

Net shares bought

-0.05%

Net buy value

-$75,446

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-09-01	Rubinstein Samuel	Director	Sell↓	Ordinary Shares (I)	525	$12.72	$6,678	0
2026-09-01	Rubinstein Samuel	Director	Buy↑	Ordinary Shares (I)	525	$12.62	$6,626	525
2026-08-27	Hess Shmuel	COO & Chief Commercial Officer	Sell↓ Filing footnotes — Ordinary Shares (Direct) The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.	Ordinary Shares	1,979	$13.13	$25,976	0
2026-08-27	Hess Shmuel	COO & Chief Commercial Officer	Convert↓ Filing footnotes — Stock Option (right to buy ordinary shares) (Direct) The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date. The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.	Stock Option (right to buy ordinary shares)	11,000	—	—	16,000
2026-08-27	Hess Shmuel	COO & Chief Commercial Officer	Sell↓ Filing footnotes — Ordinary Shares (Direct) The Reporting Person exercised 11,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 3,958 ordinary shares to the Reporting Person. All 3,958 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.	Ordinary Shares	1,979	$12.72	$25,173	0
2026-08-26	Hess Shmuel	COO & Chief Commercial Officer	Sell↓ Filing footnotes — Ordinary Shares (Direct) The Reporting Person exercised 5,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 1,865 ordinary shares to the Reporting Person. All 1,865 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.	Ordinary Shares	1,865	$13.00	$24,245	0
2026-08-26	Hess Shmuel	COO & Chief Commercial Officer	Convert↓ Filing footnotes — Stock Option (right to buy ordinary shares) (Direct) The options reported in this row are the remaining outstanding options from a grant of 39,000 options that were granted to the Reporting Person on December 1, 2023 and that have been vesting in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest equally on a quarterly basis over the following three years such that they will be fully vested on the four-year anniversary of the grant date. The Reporting Person exercised 5,000 stock options on a net (cashless) basis. Shares otherwise issuable upon exercise were withheld to satisfy the aggregate exercise price, resulting in the net issuance of 1,865 ordinary shares to the Reporting Person. All 1,865 ordinary shares received upon the net exercise were sold on the same day as reported in Table I.	Stock Option (right to buy ordinary shares)	5,000	—	—	27,000
2026-06-03	SHAMIR NACHUM	Director	Buy↑	Ordinary Shares	5,825	$14.00	$81,550	55,815
2026-06-03	SHAMIR NACHUM	Director	Buy↑	Ordinary Shares	175	$13.98	$2,446	49,990
2026-06-01	Fox David Morton	Director	Buy↑	Ordinary Shares	1,730	$14.23	$24,609	20,476
2026-06-01	Fox David Morton	Director	Buy↑	Ordinary Shares	10	$14.23	$142	20,486
2026-06-01	Fox David Morton	Director	Buy↑	Ordinary Shares	1,797	$14.00	$25,149	22,283
2026-05-29	Rubinstein Samuel	Director	Buy↑	Ordinary Shares	150	$14.33	$2,150	2,993

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–13 of 13 transactions

Key facts CIK 1593984 CUSIP M68830112 13F (30d) 3 filings 3 filers Visit website Investor relations